Published in J Biol Chem on August 22, 2010
Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides. Nature (2011) 4.34
Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis. J Clin Invest (2011) 4.21
MicroRNAs in metabolism and metabolic disorders. Nat Rev Mol Cell Biol (2012) 3.78
miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling. Proc Natl Acad Sci U S A (2011) 3.35
SREBPs: metabolic integrators in physiology and metabolism. Trends Endocrinol Metab (2011) 2.29
Inhibition of microRNA function by antimiR oligonucleotides. Silence (2012) 2.02
Regulation of eukaryotic gene expression by the untranslated gene regions and other non-coding elements. Cell Mol Life Sci (2012) 1.96
MicroRNA-26a/b and their host genes cooperate to inhibit the G1/S transition by activating the pRb protein. Nucleic Acids Res (2011) 1.79
MicroRNAs in lipid metabolism. Curr Opin Lipidol (2011) 1.79
Development of microRNA therapeutics is coming of age. EMBO Mol Med (2014) 1.60
Mir-33 regulates cell proliferation and cell cycle progression. Cell Cycle (2012) 1.60
miR-33 controls the expression of biliary transporters, and mediates statin- and diet-induced hepatotoxicity. EMBO Mol Med (2012) 1.54
Increased very low density lipoprotein (VLDL) secretion, hepatic steatosis, and insulin resistance. Trends Endocrinol Metab (2011) 1.53
Anti-miR-33 therapy does not alter the progression of atherosclerosis in low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol (2013) 1.38
MicroRNAs in metabolic disease. Arterioscler Thromb Vasc Biol (2013) 1.33
The role of microRNAs in cholesterol efflux and hepatic lipid metabolism. Annu Rev Nutr (2011) 1.30
MicroRNA-144 regulates hepatic ATP binding cassette transporter A1 and plasma high-density lipoprotein after activation of the nuclear receptor farnesoid X receptor. Circ Res (2013) 1.30
Therapeutic silencing of microRNA-33 inhibits the progression of atherosclerosis in Ldlr-/- mice--brief report. Arterioscler Thromb Vasc Biol (2013) 1.28
Plasma levels of lipometabolism-related miR-122 and miR-370 are increased in patients with hyperlipidemia and associated with coronary artery disease. Lipids Health Dis (2012) 1.24
MicroRNAs and liver disease. Transl Res (2011) 1.21
MicroRNAs in metabolism and metabolic diseases. Cold Spring Harb Symp Quant Biol (2011) 1.21
A regulatory role for microRNA 33* in controlling lipid metabolism gene expression. Mol Cell Biol (2013) 1.21
Pharmacological inhibition of a microRNA family in nonhuman primates by a seed-targeting 8-mer antimiR. Sci Transl Med (2013) 1.21
An SREBP-responsive microRNA operon contributes to a regulatory loop for intracellular lipid homeostasis. Cell Metab (2013) 1.20
MicroRNA 33 regulates glucose metabolism. Mol Cell Biol (2013) 1.19
Cholesterol regulation of receptor-interacting protein 140 via microRNA-33 in inflammatory cytokine production. FASEB J (2011) 1.18
miR-33a modulates ABCA1 expression, cholesterol accumulation, and insulin secretion in pancreatic islets. Diabetes (2012) 1.16
MicroRNA modulation of cholesterol homeostasis. Arterioscler Thromb Vasc Biol (2011) 1.14
DNA methylation of lipid-related genes affects blood lipid levels. Circ Cardiovasc Genet (2015) 1.12
Roles of microRNA on cancer cell metabolism. J Transl Med (2012) 1.11
MicroRNA Regulation of Atherosclerosis. Circ Res (2016) 1.10
New insights into the mechanism of low high-density lipoprotein cholesterol in obesity. Lipids Health Dis (2011) 1.10
MicroRNAs regulating lipid metabolism in atherogenesis. Thromb Haemost (2012) 1.06
Long-term therapeutic silencing of miR-33 increases circulating triglyceride levels and hepatic lipid accumulation in mice. EMBO Mol Med (2014) 1.04
MicroRNA-33-dependent regulation of macrophage metabolism directs immune cell polarization in atherosclerosis. J Clin Invest (2015) 1.03
Transcriptional control of hepatic lipid metabolism by SREBP and ChREBP. Semin Liver Dis (2013) 1.02
miR-33a promotes glioma-initiating cell self-renewal via PKA and NOTCH pathways. J Clin Invest (2014) 1.02
MicroRNAs in the onset and development of cardiovascular disease. Clin Sci (Lond) (2014) 0.98
Regulation of cholesterol and bile acid homeostasis by the cholesterol 7α-hydroxylase/steroid response element-binding protein 2/microRNA-33a axis in mice. Hepatology (2013) 0.97
Dual role of microRNAs in NAFLD. Int J Mol Sci (2013) 0.95
The complexity of thyroid transcription factor 1 with both pro- and anti-oncogenic activities. J Biol Chem (2013) 0.94
MicroRNA control of high-density lipoprotein metabolism and function. Circ Res (2014) 0.93
MiR-103 controls milk fat accumulation in goat (Capra hircus) mammary gland during lactation. PLoS One (2013) 0.93
Mechanistic Role of MicroRNAs in Coupling Lipid Metabolism and Atherosclerosis. Adv Exp Med Biol (2015) 0.92
Macrophage Mitochondrial Energy Status Regulates Cholesterol Efflux and Is Enhanced by Anti-miR33 in Atherosclerosis. Circ Res (2015) 0.92
Control of very low-density lipoprotein secretion by N-ethylmaleimide-sensitive factor and miR-33. Circ Res (2014) 0.92
Eyeballing cholesterol efflux and macrophage function in disease pathogenesis. Trends Endocrinol Metab (2013) 0.92
MicroRNAs and lipoproteins: a connection beyond atherosclerosis? Atherosclerosis (2012) 0.90
Regulation of lipid homeostasis by the bifunctional SREBF2-miR33a locus. Cell Metab (2011) 0.90
Metformin: On Ongoing Journey across Diabetes, Cancer Therapy and Prevention. Metabolites (2013) 0.89
A pathway approach to investigate the function and regulation of SREBPs. Genes Nutr (2013) 0.89
MicroRNA modulation of lipid metabolism and oxidative stress in cardiometabolic diseases. Free Radic Biol Med (2013) 0.88
Post-transcriptional regulation in metabolic diseases. RNA Biol (2012) 0.88
MicroRNA Regulation of Cholesterol Metabolism. Cholesterol (2012) 0.88
MicroRNA 302a is a novel modulator of cholesterol homeostasis and atherosclerosis. Arterioscler Thromb Vasc Biol (2014) 0.86
Complexity of microRNA function and the role of isomiRs in lipid homeostasis. J Lipid Res (2013) 0.86
"Micromanaging" metabolic syndrome. Cell Cycle (2011) 0.86
Cordycepin (3'-deoxyadenosine) suppressed HMGA2, Twist1 and ZEB1-dependent melanoma invasion and metastasis by targeting miR-33b. Oncotarget (2015) 0.86
Anti-atherosclerosis or No Anti-atherosclerosis: That is the miR-33 question. Arterioscler Thromb Vasc Biol (2013) 0.85
Chronic administration of proanthocyanidins or docosahexaenoic acid reverses the increase of miR-33a and miR-122 in dyslipidemic obese rats. PLoS One (2013) 0.85
miRNA and cholesterol homeostasis. Biochim Biophys Acta (2016) 0.85
MicroRNAs involved in the lipid metabolism and their possible implications for atherosclerosis development and treatment. Mediators Inflamm (2014) 0.84
Clinical Significance of Determining Plasma MicroRNA33b in Type 2 Diabetic Patients with Dyslipidemia. J Atheroscler Thromb (2016) 0.83
Therapeutic Inhibition of miR-33 Promotes Fatty Acid Oxidation but Does Not Ameliorate Metabolic Dysfunction in Diet-Induced Obesity. Arterioscler Thromb Vasc Biol (2015) 0.82
MicroRNA-33a regulates cholesterol synthesis and cholesterol efflux-related genes in osteoarthritic chondrocytes. Arthritis Res Ther (2015) 0.81
Novel concepts in HDL pharmacology. Cardiovasc Res (2014) 0.80
MicroRNAs: a connection between cholesterol metabolism and neurodegeneration. Neurobiol Dis (2014) 0.80
microRNAs and cancer metabolism reprogramming: the paradigm of metformin. Ann Transl Med (2014) 0.80
MicroRNA-33b knock-in mice for an intron of sterol regulatory element-binding factor 1 (Srebf1) exhibit reduced HDL-C in vivo. Sci Rep (2014) 0.80
microRNAs and HDL life cycle. Cardiovasc Res (2014) 0.80
MicroRNA-management of lipoprotein homeostasis. Circ Res (2014) 0.80
The plaque "micro" environment: microRNAs control the risk and the development of atherosclerosis. Curr Atheroscler Rep (2012) 0.80
MicroRNA-26a/b and their host genes synergistically regulate triacylglycerol synthesis by targeting the INSIG1 gene. RNA Biol (2016) 0.80
Growth hormone-regulated mRNAs and miRNAs in chicken hepatocytes. PLoS One (2014) 0.79
Expression of miR-33 from an SREBF2 intron targets the FTO gene in the chicken. PLoS One (2014) 0.79
Quest for new biomarkers in atherosclerosis. Mo Med (2013) 0.79
miR-33-5p, a novel mechano-sensitive microRNA promotes osteoblast differentiation by targeting Hmga2. Sci Rep (2016) 0.78
The Regulation of Reverse Cholesterol Transport and Cellular Cholesterol Homeostasis by MicroRNAs. Biology (Basel) (2015) 0.78
From evolution to revolution: miRNAs as pharmacological targets for modulating cholesterol efflux and reverse cholesterol transport. Pharmacol Res (2013) 0.78
MiR-33 connects cholesterol to the cell cycle. Cell Cycle (2012) 0.78
Identification of conserved and novel microRNAs in the Pacific oyster Crassostrea gigas by deep sequencing. PLoS One (2014) 0.78
Small RNA overcomes the challenges of therapeutic targeting of microsomal triglyceride transfer protein. Circ Res (2013) 0.78
Expression profiling of preadipocyte microRNAs by deep sequencing on chicken lines divergently selected for abdominal fatness. PLoS One (2015) 0.78
Non-coding RNAs and lipid metabolism. Int J Mol Sci (2014) 0.78
Atherosclerosis. Arterioscler Thromb Vasc Biol (2015) 0.78
Effects of hypoxic exercise training on microRNA expression and lipid metabolism in obese rat livers. J Zhejiang Univ Sci B (2014) 0.78
Systematic analysis of the regulatory functions of microRNAs in chicken hepatic lipid metabolism. Sci Rep (2016) 0.77
Comparative microRNA expression profiles of cynomolgus monkeys, rat, and human reveal that mir-182 is involved in T2D pathogenic processes. J Diabetes Res (2014) 0.77
miRNAs and High-Density Lipoprotein metabolism. Biochim Biophys Acta (2016) 0.77
Thyroid follicle development requires Smad1/5- and endothelial cell-dependent basement membrane assembly. Development (2016) 0.77
MicroRNAs in brain cholesterol metabolism and their implications for Alzheimer's disease. Biochim Biophys Acta (2016) 0.77
SREBP-1c/MicroRNA 33b Genomic Loci Control Adipocyte Differentiation. Mol Cell Biol (2016) 0.76
Micro-RNAs and High-Density Lipoprotein Metabolism. Arterioscler Thromb Vasc Biol (2016) 0.76
The miR-33 gene is identified in a marine teleost: a potential role in regulation of LC-PUFA biosynthesis in Siganus canaliculatus. Sci Rep (2016) 0.75
TXNIP regulates myocardial fatty acid oxidation via miR-33a signaling. Am J Physiol Heart Circ Physiol (2016) 0.75
MicroRNA-124 promotes hepatic triglyceride accumulation through targeting tribbles homolog 3. Sci Rep (2016) 0.75
Fibroblast growth factor 21 potentially inhibits microRNA-33 expression to affect macrophage actions. Lipids Health Dis (2016) 0.75
Detection of miR-33 Expression and the Verification of Its Target Genes in the Fatty Liver of Geese. Int J Mol Sci (2015) 0.75
The role of miRNAs in cardiovascular disease risk factors. Atherosclerosis (2016) 0.75
Nanomedicine Meets microRNA: Current Advances in RNA-Based Nanotherapies for Atherosclerosis. Arterioscler Thromb Vasc Biol (2016) 0.75
A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem (1957) 173.99
Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell (2005) 96.87
MicroRNAs: target recognition and regulatory functions. Cell (2009) 92.17
Combinatorial microRNA target predictions. Nat Genet (2005) 50.48
MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell (2007) 38.42
Silencing of microRNAs in vivo with 'antagomirs'. Nature (2005) 32.56
The impact of microRNAs on protein output. Nature (2008) 32.39
Widespread changes in protein synthesis induced by microRNAs. Nature (2008) 31.44
Nonalcoholic fatty liver disease. N Engl J Med (2002) 22.41
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest (2002) 21.08
The widespread impact of mammalian MicroRNAs on mRNA repression and evolution. Science (2005) 20.51
MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat Methods (2007) 13.94
Proliferating cells express mRNAs with shortened 3' untranslated regions and fewer microRNA target sites. Science (2008) 11.33
microRNA target predictions in animals. Nat Genet (2006) 10.76
Protein sensors for membrane sterols. Cell (2006) 8.62
MiR-33 contributes to the regulation of cholesterol homeostasis. Science (2010) 6.93
Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science (2000) 6.52
Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells. J Clin Invest (1997) 6.18
Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells. J Clin Invest (1997) 6.16
MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science (2010) 5.77
Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha. Proc Natl Acad Sci U S A (2000) 4.58
Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease. JAMA (2008) 4.41
HDL, ABC transporters, and cholesterol efflux: implications for the treatment of atherosclerosis. Cell Metab (2008) 4.34
miR-33 links SREBP-2 induction to repression of sterol transporters. Proc Natl Acad Sci U S A (2010) 3.99
Deadenylation is a widespread effect of miRNA regulation. RNA (2008) 3.98
Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice. J Clin Invest (2007) 3.89
Cardiovascular disease. N Engl J Med (2003) 3.31
Accurate microRNA target prediction correlates with protein repression levels. BMC Bioinformatics (2009) 3.21
Regulation of SREBP processing and membrane lipid production by phospholipids in Drosophila. Science (2002) 3.19
Intestinal ABCA1 directly contributes to HDL biogenesis in vivo. J Clin Invest (2006) 2.55
Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects. Mol Aspects Med (2004) 2.32
MicroRNAs silence gene expression by repressing protein expression and/or by promoting mRNA decay. Cold Spring Harb Symp Quant Biol (2006) 2.12
Expression profiling of microRNA using real-time quantitative PCR, how to use it and what is available. Methods (2010) 2.09
Fat-specific protein 27 regulates storage of triacylglycerol. J Biol Chem (2008) 2.07
The SREBP pathway in Drosophila: regulation by palmitate, not sterols. Dev Cell (2002) 2.01
Obesity-associated liver disease. J Clin Endocrinol Metab (2008) 1.86
Malonyl-CoA, a key signaling molecule in mammalian cells. Annu Rev Nutr (2008) 1.71
Mice heterozygous for a defect in mitochondrial trifunctional protein develop hepatic steatosis and insulin resistance. Gastroenterology (2005) 1.69
SREBPs: transcriptional mediators of lipid homeostasis. Cold Spring Harb Symp Quant Biol (2002) 1.62
Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH. J Hepatol (2009) 1.60
Lack of mitochondrial trifunctional protein in mice causes neonatal hypoglycemia and sudden death. J Clin Invest (2001) 1.43
Tissue-specific roles of ABCA1 influence susceptibility to atherosclerosis. Arterioscler Thromb Vasc Biol (2009) 1.36
Etomoxir, a carnitine palmitoyltransferase I inhibitor, protects hearts from fatty acid-induced ischemic injury independent of changes in long chain acylcarnitine. Circ Res (1988) 1.29
Human ABCA1 BAC transgenic mice show increased high density lipoprotein cholesterol and ApoAI-dependent efflux stimulated by an internal promoter containing liver X receptor response elements in intron 1. J Biol Chem (2001) 1.28
High-density lipoproteins: epidemiologic profile and risks of coronary artery disease. Am J Cardiol (1983) 1.28
Peroxisomes, lipid metabolism and lipotoxicity. Biochim Biophys Acta (2010) 1.25
MicroRNA-338-3p and microRNA-451 contribute to the formation of basolateral polarity in epithelial cells. Nucleic Acids Res (2009) 1.23
The mitochondrial trifunctional protein: centre of a beta-oxidation metabolon? Biochem Soc Trans (2000) 1.10
High-resolution separation and quantification of neutral lipid and phospholipid species in mammalian cells and sera by multi-one-dimensional thin-layer chromatography. Anal Biochem (1998) 1.04
Hepatic ATP-binding cassette transporter A1 is a key molecule in high-density lipoprotein cholesteryl ester metabolism in mice. Arterioscler Thromb Vasc Biol (2006) 1.01
Purification of recombinant apolipoproteins A-I and A-IV and efficient affinity tag cleavage by tobacco etch virus protease. J Lipid Res (2009) 0.99
Genome duplication events have led to a diversification in the CPT I gene family in fish. Am J Physiol Regul Integr Comp Physiol (2010) 0.92
ENU mutagenesis identifies mice with cardiac fibrosis and hepatic steatosis caused by a mutation in the mitochondrial trifunctional protein beta-subunit. Hum Mol Genet (2006) 0.91
Malonyl-CoA inhibition of peroxisomal carnitine octanoyltransferase. Biochem J (1992) 0.88
Inhibition by etomoxir of rat liver carnitine octanoyltransferase is produced through the co-ordinate interaction with two histidine residues. Biochem J (2000) 0.83
ABCA1 gene mutations, HDL cholesterol levels, and risk of ischemic heart disease. JAMA (2008) 0.83
Identification of pancreatic cancer stem cells. Cancer Res (2007) 18.36
Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol (2006) 11.36
TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth. Cell (2006) 7.49
p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr Biol (2007) 6.87
Regulation of osteoblastogenesis and bone mass by Wnt10b. Proc Natl Acad Sci U S A (2005) 4.48
Regulation of Wnt signaling during adipogenesis. J Biol Chem (2002) 3.94
MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells. PLoS One (2009) 3.66
Liver progenitor cells yield functional hepatocytes in response to chronic liver injury in mice. Gastroenterology (2012) 3.34
Embryonic ductal plate cells give rise to cholangiocytes, periportal hepatocytes, and adult liver progenitor cells. Gastroenterology (2011) 3.19
Using molecular classification to predict gains in maximal aerobic capacity following endurance exercise training in humans. J Appl Physiol (1985) (2010) 2.74
Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis. Nat Commun (2012) 2.65
Microarray analyses during adipogenesis: understanding the effects of Wnt signaling on adipogenesis and the roles of liver X receptor alpha in adipocyte metabolism. Mol Cell Biol (2002) 2.44
The sedoheptulose kinase CARKL directs macrophage polarization through control of glucose metabolism. Cell Metab (2012) 2.36
Wnt10b inhibits development of white and brown adipose tissues. J Biol Chem (2004) 2.32
Relation between liver progenitor cell expansion and extracellular matrix deposition in a CDE-induced murine model of chronic liver injury. Hepatology (2009) 2.23
Episodic coronary artery vasospasm and hypertension develop in the absence of Sur2 K(ATP) channels. J Clin Invest (2002) 2.11
Fat-specific protein 27 regulates storage of triacylglycerol. J Biol Chem (2008) 2.07
Wnt signaling protects 3T3-L1 preadipocytes from apoptosis through induction of insulin-like growth factors. J Biol Chem (2002) 2.05
CD73 (ecto-5'-nucleotidase) hepatocyte levels differ across mouse strains and contribute to mallory-denk body formation. Hepatology (2013) 2.04
Mesenchymal cells reactivate Snail1 expression to drive three-dimensional invasion programs. J Cell Biol (2009) 1.99
Rats selectively bred for low aerobic capacity have reduced hepatic mitochondrial oxidative capacity and susceptibility to hepatic steatosis and injury. J Physiol (2009) 1.95
Adipose tissue stem cells meet preadipocyte commitment: going back to the future. J Lipid Res (2011) 1.94
Critical role for hypothalamic mTOR activity in energy balance. Cell Metab (2009) 1.90
Mutant KRAS promotes hyperplasia and alters differentiation in the colon epithelium but does not expand the presumptive stem cell pool. Gastroenterology (2011) 1.86
Kupffer cell activation is a causal factor for hepatic insulin resistance. Am J Physiol Gastrointest Liver Physiol (2009) 1.85
Wnt signaling inhibits adipogenesis through beta-catenin-dependent and -independent mechanisms. J Biol Chem (2005) 1.85
Wnt6, Wnt10a and Wnt10b inhibit adipogenesis and stimulate osteoblastogenesis through a β-catenin-dependent mechanism. Bone (2011) 1.83
Roles for miRNA-378/378* in adipocyte gene expression and lipogenesis. Am J Physiol Endocrinol Metab (2010) 1.78
Wnt10b increases postnatal bone formation by enhancing osteoblast differentiation. J Bone Miner Res (2007) 1.77
The microRNA miR-8 is a conserved negative regulator of Wnt signaling. Proc Natl Acad Sci U S A (2008) 1.76
Wnt signaling promotes oncogenic transformation by inhibiting c-Myc-induced apoptosis. J Cell Biol (2002) 1.75
Wnt10b inhibits obesity in ob/ob and agouti mice. Diabetes (2007) 1.65
Metscape: a Cytoscape plug-in for visualizing and interpreting metabolomic data in the context of human metabolic networks. Bioinformatics (2010) 1.62
Phosphorylation of C/EBPalpha inhibits granulopoiesis. Mol Cell Biol (2004) 1.61
Marrow fat and bone--new perspectives. J Clin Endocrinol Metab (2013) 1.60
Reducing time and increasing sensitivity in sample preparation for adherent mammalian cell metabolomics. Anal Chem (2011) 1.58
Canonical Wnt signaling induces skin fibrosis and subcutaneous lipoatrophy: a novel mouse model for scleroderma? Arthritis Rheum (2011) 1.51
Wnt10b deficiency promotes coexpression of myogenic and adipogenic programs in myoblasts. Mol Biol Cell (2005) 1.47
Role of Wnts in prostate cancer bone metastases. J Cell Biochem (2006) 1.46
LXRbeta is required for adipocyte growth, glucose homeostasis, and beta cell function. J Biol Chem (2005) 1.44
Islet microvasculature in islet hyperplasia and failure in a model of type 2 diabetes. Diabetes (2006) 1.36
Identification of a putative tumor suppressor gene Rap1GAP in pancreatic cancer. Cancer Res (2006) 1.34
Intrinsic aerobic capacity sets a divide for aging and longevity. Circ Res (2011) 1.33
Effects of Wnt signaling on brown adipocyte differentiation and metabolism mediated by PGC-1alpha. Mol Cell Biol (2005) 1.31
Improved insulin sensitivity after weight loss and exercise training is mediated by a reduction in plasma fatty acid mobilization, not enhanced oxidative capacity. J Physiol (2009) 1.31
T-cell factor 4N (TCF-4N), a novel isoform of mouse TCF-4, synergizes with beta-catenin to coactivate C/EBPalpha and steroidogenic factor 1 transcription factors. Mol Cell Biol (2003) 1.29
Analysis of promoter methylation in stool: a novel method for the detection of colorectal cancer. Clin Gastroenterol Hepatol (2005) 1.27
Inhibitor of DNA binding 2 is a small molecule-inducible modulator of peroxisome proliferator-activated receptor-gamma expression and adipocyte differentiation. Mol Endocrinol (2008) 1.26
Role of FoxO1 in FFA-induced oxidative stress in adipocytes. Am J Physiol Endocrinol Metab (2007) 1.26
Impulsivity and inhibitory control deficits are associated with unhealthy eating in young adults. Appetite (2012) 1.15
Generating somatic mosaicism with a Cre recombinase-microsatellite sequence transgene. Nat Methods (2008) 1.14
NF-Y and CCAAT/enhancer-binding protein alpha synergistically activate the mouse amelogenin gene. J Biol Chem (2006) 1.13
Metabolome response to glucose in the β-cell line INS-1 832/13. J Biol Chem (2013) 1.12
Raf kinase inhibitory protein inhibits beta-cell proliferation. Surgery (2004) 1.12
Conditional ablation and recovery of forebrain neurogenesis in the mouse. J Comp Neurol (2009) 1.11
CCAAT/enhancer-binding protein alpha mediates induction of hepatic phosphoenolpyruvate carboxykinase by p38 mitogen-activated protein kinase. J Biol Chem (2006) 1.11
Lysine residues Lys-19 and Lys-49 of beta-catenin regulate its levels and function in T cell factor transcriptional activation and neoplastic transformation. J Biol Chem (2006) 1.11
Nestin-lineage cells contribute to the microvasculature but not endocrine cells of the islet. Diabetes (2003) 1.08
The rapidly expanding family of adipokines. Cell Metab (2007) 1.08
Continuous-flow enzyme assay on a microfluidic chip for monitoring glycerol secretion from cultured adipocytes. Anal Chem (2009) 1.07
Retort pouch processing of Chettinad style goat meat curry - a heritage meat product. J Food Sci Technol (2010) 1.07
Sox9 induction, ectopic Paneth cells, and mitotic spindle axis defects in mouse colon adenomatous epithelium arising from conditional biallelic Apc inactivation. Am J Pathol (2013) 1.07
Multiple roles for the non-coding RNA SRA in regulation of adipogenesis and insulin sensitivity. PLoS One (2010) 1.06
The impact of a managed care obesity intervention on clinical outcomes and costs: a prospective observational study. Obesity (Silver Spring) (2013) 1.06
Retinaldehyde dehydrogenase 1 coordinates hepatic gluconeogenesis and lipid metabolism. Endocrinology (2012) 1.05
Adipose tissue stem cells: the great WAT hope. Trends Endocrinol Metab (2012) 1.05
Cloning and functional characterization of the mouse fructose transporter, GLUT5. Biochim Biophys Acta (2002) 1.05
The many facets of PPARgamma: novel insights for the skeleton. Am J Physiol Endocrinol Metab (2010) 1.04
NAD+ metabolite levels as a function of vitamins and calorie restriction: evidence for different mechanisms of longevity. BMC Chem Biol (2010) 1.04
Kupffer cell depletion prevents but has no therapeutic effect on metabolic and inflammatory changes induced by a high-fat diet. FASEB J (2011) 1.04
Why and How Meet n-3 PUFA Dietary Recommendations? Gastroenterol Res Pract (2010) 1.04
Drosophila split ends homologue SHARP functions as a positive regulator of Wnt/beta-catenin/T-cell factor signaling in neoplastic transformation. Cancer Res (2007) 1.03
GSK3beta and beta-catenin modulate radiation cytotoxicity in pancreatic cancer. Neoplasia (2010) 1.03
Hepatic n-3 polyunsaturated fatty acid depletion promotes steatosis and insulin resistance in mice: genomic analysis of cellular targets. PLoS One (2011) 1.03
Distinct mechanisms of glucose lowering by specific agonists for peroxisomal proliferator activated receptor gamma and retinoic acid X receptors. J Biol Chem (2005) 1.03
Successful isolation of liver progenitor cells by aldehyde dehydrogenase activity in naïve mice. Hepatology (2012) 1.02
On the role of FOX transcription factors in adipocyte differentiation and insulin-stimulated glucose uptake. J Biol Chem (2009) 1.02
Loss of estrogen receptor 1 enhances cervical cancer invasion. Am J Pathol (2010) 1.01
Kupffer cells influence parenchymal invasion and phenotypic orientation, but not the proliferation, of liver progenitor cells in a murine model of liver injury. Am J Pathol (2011) 1.01
Artificial sweeteners stimulate adipogenesis and suppress lipolysis independently of sweet taste receptors. J Biol Chem (2013) 1.00
Untargeted LC-MS metabolomics of bronchoalveolar lavage fluid differentiates acute respiratory distress syndrome from health. J Proteome Res (2013) 1.00
Skeletal muscle gene expression in response to resistance exercise: sex specific regulation. BMC Genomics (2010) 0.99
Autologous bone marrow mononuclear cell transplantation in patients with decompensated alcoholic liver disease: a randomized controlled trial. PLoS One (2013) 0.99
The metabolic syndrome: how it may influence hepatic stellate cell activation and hepatic fibrosis. Curr Opin Clin Nutr Metab Care (2009) 0.99
Reversibly sealed multilayer microfluidic device for integrated cell perfusion and on-line chemical analysis of cultured adipocyte secretions. Anal Bioanal Chem (2010) 0.97
Regulation of cyclin D1 and Wnt10b gene expression by cAMP-responsive element-binding protein during early adipogenesis involves differential promoter methylation. J Biol Chem (2008) 0.97
The transcription factor paired-related homeobox 1 (Prrx1) inhibits adipogenesis by activating transforming growth factor-β (TGFβ) signaling. J Biol Chem (2012) 0.96
Resistance to diet-induced obesity and improved insulin sensitivity in mice with a regulator of G protein signaling-insensitive G184S Gnai2 allele. Diabetes (2007) 0.96
Increased glucose metabolism and glycerolipid formation by fatty acids and GPR40 receptor signaling underlies the fatty acid potentiation of insulin secretion. J Biol Chem (2014) 0.95
Hepatocellular carcinoma originates from hepatocytes and not from the progenitor/biliary compartment. J Clin Invest (2015) 0.95
DGAT: novel therapeutic target for obesity and type 2 diabetes mellitus. Curr Drug Targets Immune Endocr Metabol Disord (2003) 0.94
Genetic analysis of a rat model of aerobic capacity and metabolic fitness. PLoS One (2013) 0.93
Integrated metabolome and transcriptome analysis of the NCI60 dataset. BMC Bioinformatics (2011) 0.93
NADPH oxidase is not an essential mediator of oxidative stress or liver injury in murine MCD diet-induced steatohepatitis. J Hepatol (2006) 0.93
Antioxidant effects of broccoli powder extract in goat meat nuggets. Meat Sci (2012) 0.92